LIFECORE BIOMEDICAL, INC. \DE\

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent ($11.6m)
$10.6m +190.97%
$24.8m +134.46%
$411k -98.34%
($38.2m) -9392.21%
($32.7m) +14.47%
($114.7m) -251.08%
($99.6m) +13.18%
$12.0m +112.07%
($38.7m) -422.29%
Net Income (Loss) Available to Common Stockholders, Basic ($44.4m)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest ($11.4m) $10.7m $24.9m $411k ($38.2m) ($32.7m) ($114.7m) ($99.6m)
Net Income (Loss) Attributable to Noncontrolling Interest $193k $87k $94k $0 $0
Depreciation, Depletion and Amortization $9.4m $10.7m $12.4m $15.2m $18.8m $19.9m $17.9m $13.3m $8.9m $8.0m $8.0m
Amortization of Intangible Assets ($867k) $885k $969k $1.5m $2.0m $2.0m $1.4m $0 $0
Capitalized Computer Software, Amortization $269k $414k $632k $900k $800k $1.1m $500k $500k $500k
Deferred Income Tax Expense (Benefit) ($9.8m) $2.5m ($6.7m) $1.4m ($5.4m) ($7.9m) ($6.3m) $254k $156k ($119k) $136k
Share-based Payment Arrangement, Noncash Expense $3.5m $4.0m $4.4m $3.6m $2.4m $3.4m $2.6m $3.6m $6.2m $10.2m $10.2m
Payment, Tax Withholding, Share-based Payment Arrangement $0 $434k $1.5m $700k $212k $405k $789k $274k $152k $1.3m
Share-based Payment Arrangement, Expense $3.5m $4.0m $4.4m $3.6m $2.4m $3.4m $2.6m $3.6m $6.2m $10.2m $10.2m
Goodwill and Intangible Asset Impairment $13.0m $0 $78.1m $1.3m $0
Goodwill, Impairment Loss $0 $0 $0 $0 $7.9m $0 $20.0m $13.0m
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $34.0m $0 $0 $2.0m $14.2m
Restructuring Costs and Asset Impairment Charges $14.8m $10.1m $5.2m $640k $1.4m
Other Nonoperating Income (Expense) $1.2m $900k $2.9m $1.6m ($4.4m) ($11.7m) $641k ($1.2m) ($3.1m) ($3k)
Changes in operating assets and liabilities:
Increase (Decrease) in Inventories $508k ($855k) $6.5m $10.9m $12.2m $3.4m $6.0m $14.8m ($862k) ($7.7m) $7.7m
Inventory Write-down $4.9m $800k
Increase (Decrease) in Accounts Payable ($4.1m) ($5.2m) $5.0m $19.1m ($1.2m) ($6.0m) $9.3m $16.0m ($6.7m) ($1.7m) ($1.7m)
Gain (Loss) on Disposition of Other Assets ($7.8m)
Net Cash Provided by (Used in) Operating Activities $21.8m
$29.3m +34.63%
$19.8m -32.56%
$16.0m -19.01%
($17.0m) -206.37%
$15.0m +188.12%
($24.4m) -262.48%
($17.4m) +28.52%
($217k) +98.76%
($206k) +5.07%
($206k) 0.00%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $40.9m $22.6m $33.6m $44.7m $26.7m $23.8m $26.2m $6.9m $18.4m $13.4m ($13.4m)
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property ($46k) ($586k) ($157k) ($188k) ($26.7m) ($23.8m) $2.3m $6.9m ($18.4m) ($13.4m) $7.4m
Gain (Loss) on Disposition of Property Plant Equipment ($40.9m) ($22.6m) ($33.6m) ($44.7m) ($143k) ($61k) ($152k) ($38k) ($18k) ($13.4m) $7.4m
Payments to Acquire Businesses, Net of Cash Acquired $59.9m $0 $0 $0
Net Cash Provided by (Used in) Investing Activities ($41.6m) ($25.0m) ($35.6m) ($96.8m) ($23.9m) ($10.9m) $81.8m ($4.8m) ($17.9m) ($6.4m) ($6.4m)
Cash flows from financing activities:
Repayments of Long-term Debt $14.7m $57.2m $5.1m $5.1m $11.1m $114.1m $86.4m $123.7m $0 ($146.7m)
Gain (Loss) on Extinguishment of Debt ($1.2m) $0 ($23.7m) $0
Proceeds from Issuance of Long-term Debt $26.7m $50.0m $60.0m $27.5m $170.0m $20.0m $150.0m $131.0m
Proceeds from Issuance of Common Stock $322k $706k $56k $327k $30k $0 $0 $4.8m $0 $23.9m $23.9m
Proceeds from (Payments for) Other Financing Activities ($1.4m)
Net Cash Provided by (Used in) Financing Activities $15.6m
($8.8m) -156.51%
$13.3m +251.03%
$79.0m +494.54%
$40.0m -49.36%
($3.4m) -108.54%
($57.0m) -1567.77%
$39.7m +169.62%
$7.5m -81.09%
$6.4m -14.45%
$6.4m 0.00%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($4.2m) ($4.5m) ($2.5m) ($1.8m) ($912k) $742k $348k $17.4m ($10.6m) ($197k) $8.3m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $553k $1.3m $1.6m $19.1m $8.5m $8.3m $8.3m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Proceeds from Stock Options Exercised $0 $0 $724k $0
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $2.3m $5.6m $10.1m $13.2m $16.9m $31.0m $2.7m $1.9m
Income Taxes Paid, Net ($1.1m) ($7.7m) $441k $23k $72k $46k
Additional Financial Items
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal ($336k) $0
Gain (Loss) on Termination of Lease $2.6m
Gain (Loss) Related to Litigation Settlement ($2.6m) $0
Goodwill $49.6m $54.8m $54.5m $76.7m $69.4m $69.4m $13.9m $13.9m $13.9m $13.9m $13.0m
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent ($38.7m)
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $25.8m $2.1m ($38.2m) ($32.7m) ($63.5m) ($64.2m) $9.3m
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($838k) ($1.7m) $0 $0 ($51.2m) ($35.3m) $2.7m
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent $0
Income Tax Expense (Benefit) ($7.4m) $4.3m ($9.4m) $1.5m ($13.1m) ($7.8m) ($5.9m) $308k $183k $43k
Investment Income, Interest $71k $16k $211k $145k $103k $48k $81k $68k $333k
Operating Expenses $90.7m $67.7m $64.8m $75.5m $113.5m $95.0m $109.0m $49.8m $50.7m
Financing Receivable, Credit Loss, Expense (Reversal) $163k $263k
Restructuring Costs $17.3m $17.6m $9.0m $4.2m
Revenue from Contract with Customer, Including Assessed Tax $557.6m $590.4m $544.2m $185.8m $103.3m $128.3m $128.9m
Unrealized Gain (Loss) on Derivatives $39.5m $409k